Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 856 AL 870

Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction

Recke A, Oei A, Hübner F, Fechner K, Graf J, Hagenah J, May C, Woitalla D, Salmen A, Zillikens D, Gold R, Schlumberger W, Schmidt E.

Br J Dermatol. 2016 Aug;175(2):407-9. doi: 10.1111/bjd.14538. Epub 2016 May 18.

Effects of movement imitation training in Parkinson's disease: A virtual reality pilot study

Robles-García V, Corral-Bergantiños Y, Espinosa N, García-Sancho C, Sanmartín G, Flores J, Cudeiro J, Arias P.

Parkinsonism Relat Disord. 2016 May;26:17-23. doi: 10.1016/j.parkreldis.2016.02.022. Epub 2016 Mar 2.

The Striatum and Subthalamic Nucleus as Independent and Collaborative Structures in Motor Control

Tewari A, Jog R, Jog MS.

Front Syst Neurosci. 2016 Mar 1;10:17. doi: 10.3389/fnsys.2016.00017. eCollection 2016.

Psychosocial Modulators of Motor Learning in Parkinson's Disease

Zemankova P, Lungu O, Bares M.

Front Hum Neurosci. 2016 Feb 29;10:74. doi: 10.3389/fnhum.2016.00074. eCollection 2016.

Role of the Retromer Complex in Neurodegenerative Diseases

Li C, Shah SZ, Zhao D, Yang L.

Front Aging Neurosci. 2016 Mar 1;8:42. doi: 10.3389/fnagi.2016.00042. eCollection 2016.

Astrocytes As the Main Players in Primary Degenerative Disorders of the Human Central Nervous System

Capani F, Quarracino C, Caccuri R, Sica RE.

Front Aging Neurosci. 2016 Mar 4;8:45. doi: 10.3389/fnagi.2016.00045. eCollection 2016.

The Molecular Links of Re-Emerging Therapy: A Review of Evidence of Brahmi (Bacopa monniera)

Mathur D, Goyal K, Koul V, Anand A.

Front Pharmacol. 2016 Mar 4;7:44. doi: 10.3389/fphar.2016.00044. eCollection 2016.

Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches

Salahuddin P, Fatima MT, Abdelhameed AS, Nusrat S, Khan RH.

Eur J Med Chem. 2016 May 23;114:41-58. doi: 10.1016/j.ejmech.2016.02.065. Epub 2016 Mar 2.

Primary brain calcification in patients undergoing treatment with the biphosphanate alendronate

Oliveira JR, Oliveira MF.

Sci Rep. 2016 Mar 15;6:22961. doi: 10.1038/srep22961.

Measuring the Burden of Hospitalization in Patients with Parkinson´s Disease in Spain

Gil-Prieto R, Pascual-Garcia R, San-Roman-Montero J, Martinez-Martin P, Castrodeza-Sanz J, Gil-de-Miguel A.

PLoS One. 2016 Mar 15;11(3):e0151563. doi: 10.1371/journal.pone.0151563. eCollection 2016.

FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up Study

Hammesfahr S, Antke C, Mamlins E, Beu M, Wojtecki L, Ferrea S, Dinkelbach L, Moldovan AS, Schnitzler A, Müller HW, Südmeyer M.

Neurodegener Dis. 2016;16(5-6):342-7. doi: 10.1159/000443667. Epub 2016 Mar 16.

Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders

Kalkman HO, Feuerbach D.

Cell Mol Life Sci. 2016 Jul;73(13):2511-30. doi: 10.1007/s00018-016-2175-4. Epub 2016 Mar 15.

Neuronal circuits and physiological roles of the basal ganglia in terms of transmitters, receptors and related disorders

Yamada K, Takahashi S, Karube F, Fujiyama F, Kobayashi K, Nishi A, Momiyama T.

J Physiol Sci. 2016 Nov;66(6):435-446. doi: 10.1007/s12576-016-0445-4. Epub 2016 Mar 15.

Is Nitric Oxide Assuming a Janus-Face in The Central Nervous System?

Ockelford F, Saada L, Gazit E, de Mel A.

Curr Med Chem. 2016 May 27;23(16):1625-37. doi: 10.2174/0929867323666160316124137.

Tracking of iron-labeled human neural stem cells by magnetic resonance imaging in cell replacement therapy for Parkinson's disease

Ramos-Gómez M, Martínez-Serrano A.

Neural Regen Res. 2016 Jan;11(1):49-52. doi: 10.4103/1673-5374.169628.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias